Allogeneic human chondrocyte is an emerging therapy that can be used for cartilage repair and other indications. Only few players are involved in the development of this treatment procedure. Allogeneic human articular chondrocytes (hAC) could be a good alternative; however, the possibility of immunological incompatibility between recipient and hAC donor should be considered.
This report contains market size and forecasts of Allogeneic Human Chondrocyte in Global, including the following market information:
Global Allogeneic Human Chondrocyte Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Allogeneic Human Chondrocyte market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hospitals Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Allogeneic Human Chondrocyte include Kolon TissueGene, Inc., ISTO Technologies Inc., Zimmer Biomet, Genzyme, CellGenix and EMD Serono, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Allogeneic Human Chondrocyte companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Allogeneic Human Chondrocyte Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Allogeneic Human Chondrocyte Market Segment Percentages, by Type, 2021 (%)
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Global Allogeneic Human Chondrocyte Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Allogeneic Human Chondrocyte Market Segment Percentages, by Application, 2021 (%)
Osteoarthritis
Musculoskeletal System Disorders
Others
Global Allogeneic Human Chondrocyte Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Allogeneic Human Chondrocyte Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Allogeneic Human Chondrocyte revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Allogeneic Human Chondrocyte revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Kolon TissueGene, Inc.
ISTO Technologies Inc.
Zimmer Biomet
Genzyme
CellGenix
EMD Serono